Stocks · Health care · Pharmaceutical Preparations

Vanda Pharmaceuticals Inc.

VNDA Clue Score24
United States Fiscal year ends December CIK 0001347178 Results filed 28 Oct 2026

What the insiders did Net buying

By person

12 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Charles Cliff Duncan
Director
$38.09K (3)
—
+$38.09K
108,701
0.1798%
$413.52K
—
Mihael Hristos Polymeropoulos
President and CEO
—
—
—
2,704,496
4.47%
$10.29M
+44.5%
Gunther Birznieks
SVP, Business Development
—
—
—
494,197
0.8174%
$1.88M
+57.6%
Kevin Patrick Moran
SVP, CFO & Treasurer
—
—
—
411,380
0.6804%
$1.56M
+79.8%
Timothy Williams
SVP & General Counsel
—
—
—
377,450
0.6243%
$1.44M
+91.8%
Joakim Wijkstrom
SVP, Chief Marketing Officer
—
—
—
333,469
0.5515%
$1.27M
+156.9%
Richard W Dugan
Director
—
—
—
219,054
0.3623%
$833.33K
+85.3%
Phaedra Chrousos
Director
—
—
—
164,950
0.2728%
$627.50K
+157.2%
Anne Sempowski Ward
Director
—
—
—
160,667
0.2657%
$611.21K
+168.5%
Tage Honore
Director
—
—
—
135,069
0.2234%
$513.83K
+110.2%
Stephen Ray Mitchell
Director
—
—
—
112,846
0.1866%
$429.29K
+126.3%
Daniel Patrick McGuire
SVP, GC and Secretary
—
—
—
109,982
0.1819%
$418.39K
+266.8%